Author:
Wang Chao,Liu Xiao-Wen,Xiao Ting,Xu Zhi-Qiang,Cao Shuang,Wang Hai-Feng,Yan Qiong-Jiao,Gu Shuang-Xi,Zhu Yuan-Yuan
Funder
National Natural Science Foundation of China
Wuhan International Scientific and Technological Cooperation Project
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics
Reference20 articles.
1. Das AK, Chen BP, Story MD, Sato M, Minna JD, Chen DJ, Nirodi CS (2007) Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFR-mediated radioprotection in non-small cell lung carcinoma. Cancer Res 67:5267–5274
2. Felip E, Rosell R (2007) Testing for excision repair cross-complementing 1 in patients with non-small-cell lung cancer for chemotherapy response. Expert Rev Mol Diagn 7:261–268
3. Gajiwala KS, Feng J, Ferre R, Ryan K, Brodsky O, Weinrich S, Kath JC, Stewart A (2013) Insights into the aberrant activity of mutant EGFR kinase domain and drug recognition. Structure 21:209–219
4. Harandi A, Zaidi AS, Stocker AM, Laber DA (2009) Clinical efficacy and toxicity of anti-EGFR therapy in common cancers. J Oncol 2009:1–14
5. Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2019) SEER Cancer Statistics Review, 1975–2016. National Cancer Institute, Bethesda, MD
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献